| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.22 | 9e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.21 | 5e-05 |